Nurseries Clearview
Positive demographics and a highly fragmented market means the UK nursery sector remains attractive to both corporate nursery chains and financial investors.
Maximising opportunities
We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Our latest transactions
-
Clearwater Advisers
Adviser to Courlancy Santé in its partnership with the Group Saint-Gatien
View more -
Clearwater Advisers
Adviser to Sagesse Retraite Santé on raising capital from Arkéa Capital, Bpifrance and Macif
View more -
Clearwater Advisers
Adviser to the shareholders of France Thermes on the acquisition of Compagnie de Vichy
View more -
Clearwater Advisers
Adviser to the shareholders of Groupe Clinique Alpes-Belledonne on its sale to C2S
View more -
Clearwater Advisers
Adviser to 5 Santé on financing for the acquisition of the clinique Gustav Zander
View more -
Clearwater Advisers
Adviser to Groupe Polyclinique du Parc Rambot on its sale of a minority stake to Groupe Saint Gatien
View more -
Clearwater Advisers
Adviser to M&J Airlaid Products on its sale to Mölnlycke
View more -
Clearwater Advisers
Adviser to Partnerships in Children's Services Core Assets Group
View more -
Clearwater Advisers
Adviser to Waterland Private Equity on its acquisition of Sandcastle Care
View more -
Clearwater Advisers
Adviser to LDC on its sale of Prism Medical UK to Limerston Capital
View more -
Clearwater Advisers
Adviser to Firtal Group on its sale to Matas
View more
Luc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
Our Healthcare Team
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 40
deals advised upon
in the last 5 years
€4.6bn
in deal value
over the last 5 years
45%
deals involving PE
in the last 5 years
Insights
-
-
Healthcare Report
The M&A market in healthcare across Europe remains extremely vibrant, with the potential to create pan-European offerings in specific sub-sectors.
Read more -
Healthcare blog
Clearwater International's regular commentary covering all areas of the healthcare sector.
Read more
